Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
1
11%
Ph phase_1
3
33%
Ph phase_2
5
56%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
5(55.6%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

55.6%

5 of 9 finished

Non-Completion Rate

44.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(4)

Detailed Status

Completed5
Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
62.5%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (33.3%)
Phase 25 (55.6%)
N/A1 (11.1%)

Trials by Status

withdrawn111%
completed556%
terminated333%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)

NCT03565939
completedphase_1

Trichuris Suis Ova in Autism Spectrum Disorders

NCT01040221
terminatedphase_1

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

NCT01948271
completednot_applicable

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

NCT01433471
terminatedphase_2

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

NCT01413243
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03565939Phase 2

Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)

Completed
NCT01040221Phase 1

Trichuris Suis Ova in Autism Spectrum Disorders

Completed
NCT01948271Phase 1

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Terminated
NCT01433471Not Applicable

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

Completed
NCT01413243Phase 2

Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

Terminated
NCT02140112Phase 2

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder

Terminated
NCT02011269Phase 2

TSO for Plaque Psoriasis

Withdrawn
NCT01434693Phase 1

Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease

Completed
NCT01006941Phase 2

Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9